TNON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. TNON is in a clear short- and long-term downtrend (bearish MA stack, weakening MACD) and is trading below key support levels with no near-term news catalysts and no Intellectia buy signals. Given an impatient stance (not willing to wait for a cleaner setup), the risk/reward is unfavorable at the current price zone (~0.886 post-market).
Trend/structure: Bearish (SMA_200 > SMA_20 > SMA_5), confirming price is trending down across timeframes.
Momentum: MACD histogram is negative (-0.00171) and negatively expanding, indicating bearish momentum is strengthening.
RSI: RSI_6 at 23 is oversold (despite the provided label), which can allow for a short bounce, but oversold can persist in strong downtrends.
Key levels: Current price (0.886) is below the pivot (0.943) and below S1 (0.899), drifting toward S2 (0.871). Overhead resistance is 0.943 then 0.988–1.015.
Pattern/odds: Similar-pattern projection shows ~50% chance of -3.58% next day and -2.84% next week, with a +5.95% next-month bias—suggesting near-term downside risk dominates.
Intellectia Proprietary Trading Signals
Revenue grew +32.24% YoY in 2025/Q3 and gross margin improved to 65.9% (better unit economics). Analyst coverage (Alliance Global) still carries a Buy rating despite a reduced target. Oversold RSI can sometimes trigger a reflex bounce, and the 1-month pattern projection is modestly positive (+5.95%).
Strong bearish technicals (bearish MA stack + MACD worsening) with price below pivot and below S1 support. Regular session performance was weak (-3.90%) with only flat/weak after-hours stabilization. EPS deteriorated sharply YoY (EPS -0.4, down ~88.98% YoY), signaling ongoing profitability pressure. No news flow in the last week (no obvious catalyst to reverse sentiment quickly). Hedge fund and insider activity are neutral (no supportive accumulation signal). No recent congress trading data available (no influential buyer/seller signal).
Latest quarter: 2025/Q3. Revenue increased to $1.173M (+32.24% YoY), and gross margin rose to 65.9% (improved). Net income remained negative at -$3.339M but improved slightly YoY (~+4.87% improvement in loss). However, EPS dropped to -0.40 (worse YoY), indicating per-share losses deepened despite revenue/margin gains—still a cash-burn/early-commercial profile.
Recent trend: Alliance Global (2025-11-14) lowered the price target to $2.50 from $2.75 but reiterated a Buy after Q3, citing lowered forecasts. Wall Street pro view (based on provided data): Pros—still rated Buy with a target well above current price, suggesting perceived upside if execution improves. Cons—price target cut signals reduced confidence/expectations; fundamentals still loss-making with weaker EPS; near-term technicals are decisively bearish, which can overwhelm longer-term upside narratives.
